KVYO: The Beat-and-Raise That Got Booed Off Stage

# KVYO: The Beat-and-Raise That Got Booed Off Stage

Here's a fun trick if you want to watch Wall Street's psychology curdle in real time: report 26% revenue growth, beat consensus by nine million bucks, raise full-year guidance, and then watch your stock get sold anyway. That's exactly what happened to Klaviyo on August 5th, and it's the reason this name is worth talking about instead of scrolling past.

Let's start with what actually went right, because it's a lot. Q2 revenue came in at $370.6 million, up 26% year-over-year, comfortably ahead of the ~$362 million the Street was modeling. EPS landed right on the $0.19 consensus — no fireworks there, but no disaster either. The customer base cracked 205,000, and — this is the number that matters — customers generating $50,000+ in ARR grew 36% year-over-year. That's not a company coasting on Shopify SMBs anymore; that's a company climbing upmarket into real enterprise accounts. Add in the fact that 20% of ARR now comes from customers using three or more products, and you've got a platform story, not a point-solution story. Management also nudged full-year revenue guidance up about $12 million at the midpoint, to $1.526–$1.534 billion.

So why did shares slide on this print instead of rip? Two words: margin guidance. Klaviyo trimmed its full-year non-GAAP operating income outlook to $212–$218 million, pointing to costs from the Agency acquisition and continued product investment. And buried in the guide was a tell that bears immediately pounced on — Q3 revenue guidance of just 21.5–22.5% growth, a clean step-down from Q2's 26%. Put those two things together — profitability getting pushed further out, growth visibly decelerating — and you understand why a beat-and-raise quarter turned into a "sell the news" event. The market wasn't wrong to notice; it just may be overreacting to the noise.

Because here's the tension that makes this stock genuinely interesting rather than just another software name in purgatory: analyst price targets still cluster around $27–$30, with a range stretching to $35, even after a wave of target cuts (some firms trimming $3, others as much as $16). That's the kind of split-screen that gets quant models excited — deteriorating sentiment sitting on top of improving fundamentals. Wells Fargo cut its target to $22 while Macquarie actually raised its to $19 around the same window, which tells you the Street itself hasn't agreed on the story yet.

Then there's the stuff under the hood that doesn't show up in the headline print: gross margins sitting north of 74%, a fortress balance sheet with roughly $984 million in cash and minimal debt, and insider ownership above 63% — founders and employees who still have real skin in this game. Operating cash flow did dip from $93 million to $34 million quarter-over-quarter, which is worth watching, and a CFO transition adds a layer of "wait and see" that nobody loves heading into a print. Layer on 22% short interest and you've got a stock primed to move violently in either direction on any incremental data point.

My take: this is a "show me" stock, not a "trust me" stock. The bull case — durable mid-20s growth at $1.5B+ scale, enterprise traction, multi-product stickiness, AI products like Composer starting to show up in the numbers — is real and it's backed by actual data, not vibes. But the bear case isn't hand-waving either: margins are getting pushed out further than investors were promised, and the Q3 guide is the first real crack in the growth-rate armor. Whether that's a one-quarter digestion after an acquisition or the start of a genuine deceleration trend is the single most important thing to watch between now and the next print, expected in early-to-mid November with consensus EPS around $0.21.

If you believe management can convert AI monetization and upmarket momentum into durable 20%+ growth while finally getting operating leverage moving in the right direction, the gap between today's price and the $27–$30 consensus target is the trade. If you think the Q3 guide is the canary, this is a value trap wearing a growth-stock costume. I'd rather watch the cash-flow line and the Q3 actuals than the target-price headlines — that's where this story actually gets decided.